Am I a Candidate for Low BMI Surgery?
The answers to these questions depend on who you ask. To start, let’s get to know a few who’s who:
The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research.
The NIH guidelines for weight loss surgery state that bariatric surgical procedures can be considered for patients who have a BMI greater than 40 kg/m2 or a BMI greater than 35 kg/m2 with major weight-related medical problems (such as diabetes).
The problem is the guideline was issued over 30 years ago. This means that many patients are receiving outdated guidance.
How come I was previously told that I am not a qualified candidate for weight loss surgery if bariatric procedures help me become healthier and lose weight?
You may have been told that you weren’t qualified for weight loss surgery if your insurance company didn’t support it.
Returning to definitions — an insurance company is the entity that pays for your surgery. Furthermore, insurance companies follow the guidelines of the NIH.
Meanwhile, the American Society for Metabolic and Bariatric Surgery (ASMBS) is the governing body of bariatric surgeries and bariatric surgeons in the United States. Their guidelines regarding bariatric surgery are updated very frequently based on cutting-edge research and new discoveries.
The most updated ASMBS* position statement regarding weight loss surgery for low BMI patients is as follows:
For patients with a BMI of 30 to 35 kg/m2 and obesity-related co-morbidities who do not achieve substantial, durable weight loss and co-morbidity improvement with reasonable nonsurgical methods, bariatric surgery should be offered as an option for suitable individuals. In this population, surgical intervention should be considered after failure of nonsurgical treatments. Particularly given the presence of high-quality data in patients with type 2 diabetes, bariatric and metabolic surgery should be strongly considered for patients with a BMI of 30 to 35 kg/m2 and type 2 diabetes.
For the full document from the ASMBS, see here.